Goldman Sachs Group »

Centessa Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Centessa Pharmaceuticals (CNTA) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Centessa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Centessa Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Centessa Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $197k 25k 7.96
2023-09-30 $69k 11k 6.47
2023-06-30 $66k 11k 6.19
2023-03-31 $42k 11k 3.85
2022-12-31 $47k 15k 3.10
2022-06-30 $81k 17k 4.90